Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-11-12 Sale | 2020-11-13 4:08 pm | TCR2 THERAPEUTICS INC. | TCRR | Hofmeister Robert Chief Scientific Officer | 20,000 | $25.1 | $502,000 | 76,928 (Direct) | View |
| 2020-10-29 Sale | 2020-11-02 2:00 pm | TCR2 THERAPEUTICS INC. | TCRR | Hofmeister Robert Chief Science Officer | 20,000 | $19.1 | $382,000 | 61,196 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-06 Option Award | 2024-06-10 5:00 pm | N/A 2034-06-05 | Alaunos Therapeutics Inc. | TCRT | Hofmeister Robert Director | 12,800 | $0 | 12,800 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-08 5:24 pm | N/A 2033-06-05 | Alaunos Therapeutics Inc. | TCRT | Hofmeister Robert Director | 100,000 | $0 | 100,000 (Direct) | View |
| 2023-03-30 Option Award | 2023-04-19 5:00 pm | N/A 2033-03-29 | Alaunos Therapeutics Inc. | TCRT | Hofmeister Robert Director | 166,667 | $0 | 166,667 (Direct) | View |
| 2021-12-09 Option Award | 2021-12-10 4:30 pm | N/A 2031-12-08 | TCR2 THERAPEUTICS INC. | TCRR | Hofmeister Robert Chief Scientific Officer | 100,000 | $0 | 145,850 (Direct) | View |
| 2020-12-22 Exercise | 2020-12-23 5:26 pm | N/A 2026-12-13 | TCR2 THERAPEUTICS INC. | TCRR | Hofmeister Robert Chief Scientific Officer | 7,000 | $0 | 74,582 (Direct) | View |
| 2020-12-22 Exercise | 2020-12-23 5:26 pm | N/A N/A | TCR2 THERAPEUTICS INC. | TCRR | Hofmeister Robert Chief Scientific Officer | 7,000 | $0.74 | 74,582 (Direct) | View |
| 2020-12-10 Option Award | 2020-12-11 06:11 am | N/A 2030-12-09 | TCR2 THERAPEUTICS INC. | TCRR | Hofmeister Robert Chief Scientific Officer | 76,000 | $0 | 114,850 (Direct) | View |
| 2020-11-12 Exercise | 2020-11-13 4:08 pm | 2018-12-07 2027-12-07 | TCR2 THERAPEUTICS INC. | TCRR | Hofmeister Robert Chief Scientific Officer | 20,000 | $0 | 76,928 (Direct) | View |
| 2020-11-12 Exercise | 2020-11-13 4:08 pm | N/A N/A | TCR2 THERAPEUTICS INC. | TCRR | Hofmeister Robert Chief Scientific Officer | 20,000 | $0.74 | 76,928 (Direct) | View |
| 2020-10-29 Exercise | 2020-11-02 2:00 pm | 2018-12-07 2027-12-07 | TCR2 THERAPEUTICS INC. | TCRR | Hofmeister Robert Chief Science Officer | 20,000 | $0 | 61,196 (Direct) | View |
| 2020-10-29 Exercise | 2020-11-02 2:00 pm | N/A N/A | TCR2 THERAPEUTICS INC. | TCRR | Hofmeister Robert Chief Science Officer | 20,000 | $0.74 | 61,196 (Direct) | View |